| 3T04: reference: Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis., Grebien F, Hantschel O, Wojcik J, Kaupe I, Kovacic B, Wyrzucki AM, Gish GD, Cerny-Reiterer S, Koide A, Beug H, Pawson T, Valent P, Koide S, Superti-Furga G, Cell. 2011 Oct 14;147(2):306-19. PMID: 22000011 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).